- Home
- INDV vs CPRI Comparison
INDV vs CPRI Comparison
Compare INDV & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDV
- CPRI
- Stock Information
- Founded
- INDV 1994
- CPRI 1981
- Country
- INDV United States
- CPRI United Kingdom
- Employees
- INDV N/A
- CPRI N/A
- Industry
- INDV Biotechnology: Pharmaceutical Preparations
- CPRI Apparel
- Sector
- INDV Health Care
- CPRI Consumer Discretionary
- Exchange
- INDV Nasdaq
- CPRI Nasdaq
- Market Cap
- INDV 1.9B
- CPRI 2.2B
- IPO Year
- INDV N/A
- CPRI 2011
- Fundamental
- Price
- INDV $22.77
- CPRI $21.35
- Analyst Decision
- INDV Strong Buy
- CPRI Buy
- Analyst Count
- INDV 4
- CPRI 11
- Target Price
- INDV $23.75
- CPRI $23.64
- AVG Volume (30 Days)
- INDV 2.1M
- CPRI 2.6M
- Earning Date
- INDV 10-23-2025
- CPRI 11-06-2025
- Dividend Yield
- INDV N/A
- CPRI N/A
- EPS Growth
- INDV N/A
- CPRI N/A
- EPS
- INDV 0.42
- CPRI N/A
- Revenue
- INDV $1,173,000,000.00
- CPRI $4,391,000,000.00
- Revenue This Year
- INDV N/A
- CPRI N/A
- Revenue Next Year
- INDV $3.00
- CPRI $3.87
- P/E Ratio
- INDV $54.60
- CPRI N/A
- Revenue Growth
- INDV 2.27
- CPRI N/A
- 52 Week Low
- INDV $7.33
- CPRI $11.86
- 52 Week High
- INDV $25.10
- CPRI $43.34
- Technical
- Relative Strength Index (RSI)
- INDV 45.91
- CPRI 53.54
- Support Level
- INDV $24.30
- CPRI $20.42
- Resistance Level
- INDV $25.10
- CPRI $21.96
- Average True Range (ATR)
- INDV 0.65
- CPRI 0.93
- MACD
- INDV -0.45
- CPRI -0.06
- Stochastic Oscillator
- INDV 17.67
- CPRI 59.33
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
About CPRI Capri Holdings Limited
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. Capri also owns a third brand, Versace, but has agreed to sell it to Prada. John Idol has served as Capri's CEO since 2003.